CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for NeoGenomics, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

NeoGenomics, Inc.
9490 Neogenomics Way
Phone: (239) 768-0600p:239 768-0600 FORT MYERS, FL  33912  United States Ticker: NEONEO
Business Summary
NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes--Yes

Industries
SIC Code Description
8734 Testing laboratories
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Lynn A.Tetrault 61 8/15/2022 6/12/2015
Chief Executive Officer, Director Christopher M.Smith 61 8/15/2022 8/15/2022
Chief Financial Officer Jeffrey S.Sherman 58 12/7/2022 12/7/2022
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Inivata Limited The Portway Building Cambridge United Kingdom
Clarient Diagnostic Services, Inc. 31 Columbia Aliso Viejo CA United States
Clarient, Inc. 31 Columbia Aliso Viejo CA United States
3 additional Subsidiary records available in full report.

Business Names
Business Name
Clarient Diagnostic Services, Inc.
Clarient, Inc.
Cynogen, Inc.
16 additional Business Names available in full report.

General Information
Number of Employees: 2,100 (As of 12/31/2023)
Outstanding Shares: 128,360,871 (As of 11/1/2024)
Shareholders: 645
Stock Exchange: NASD
Federal Tax Id: 742897368
Fax Number: (775) 329-0852


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024